All analyses
AI analysis

Bukit Darah PLC: research report

Moderately undervaluedbullishNov 14, 2026

Evidence points to a stronger underlying business than the moderately undervalued price suggests: September operating profit grew 28.6% as margin widened. The catch is that the quarter supplied 122.4% of trailing EPS.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Why bullish

  • September revenue grew 14.0% year-on-year while operating profit grew 28.6%, showing that the latest improvement came from the businesses rather than only below-the-line items.
  • The September operating margin widened to 18.8% from 16.7%, and the result ranks third among seven comparable September quarters.
  • The market-wide valuation score is 61 of 100 on price against book value, earnings and dividends, placing BUKI in the moderately undervalued band.

Against this. The September quarter contributed 122.4% of trailing EPS, so the earnings supporting the current valuation rest heavily on one quarter.

Operating margin
18.8%sector 9.7%
from 16.7% a year earlier
Net margin
12.1%sector 3.0%
from 11.9% a year earlier, revenue +14.0%
Return on equity
6.3%sector 10.2%
full year to Mar 31, 2026
P/E
19.8sector 14.2
earnings Rs 43.50 per share, year to Mar 2026
P/B
1.06sector 1.20
book Rs 814.34 per share
Dividend yield
2.35%sector 2.08%
46.3% of earnings paid out

Current figures, updated daily from filings to Sep 30, 2026. The report below was written on Nov 14, 2026. Sector figures are the median of 22 listed companies in the same sector.

Overview

Bukit Darah is a diversified group spanning palm plantations, oils and fats, beverages, leisure, property and portfolio management across Sri Lanka and overseas operations. The latest September quarter showed a materially stronger operating result, reversing the weakness visible in the preceding March quarter and making the durability of this recovery the central issue.

Price performance

BUKI closed at LKR 855 on 13 November 2026. The share fell 28.7% over one year against a 4.7% fall in the ASPI, so its decline was much steeper than the broader market's over that period.

It sits 14.6% of the way up its 52-week range, close to the low rather than the high. Trading activity has been quieter than its own recent norms, and liquidity is exceptionally limited: a LKR 1 million order is more than everything that trades on a typical day, at 2504% of it. The three-year record contains one fall of 15% or more, a 33.3% decline that has not yet recovered.

Valuation

The P/E is 19.7 times, meaning the market price represents LKR 19.70 for each LKR 1 of trailing profit, and it is at the 81st percentile among sector peers with reported earnings multiples. That is a premium earnings valuation within diversified holdings despite the market-wide score placing the shares in the moderately undervalued band.

The P/B is 1.05 times, or LKR 1.05 paid for each LKR 1 of net assets, while the latest audited return on equity was 6.3%. BUKI is cheaper than 65% of days since February 2012 on P/B, so the price is low relative to much of its own book-value record even though its earnings multiple is high against peers.

The 2.4% dividend yield is slightly below the sector median, and the FY2027 interim payment is below the FY2026 interim payment, although the current financial year is incomplete. A buyer at this price is relying on the September quarter, which supplied 122.4% of trailing EPS; at its year-ago net margin, the P/E would be 20.0 times.

News and sentiment

Direct company coverage is thin. The 90-day news set contains four material articles, all classified negative, but the supplied material item is a routine first interim dividend reported on 15 July 2026.

The LKR 5.73 dividend went ex-date on 24 July 2026, so a buyer today does not receive it.

Financials

September-quarter revenue rose 14.0% year-on-year to LKR 103.3 billion, while operating profit increased 28.6% to LKR 19.4 billion. The operating gain therefore outpaced sales growth, indicating improved profitability in the businesses themselves.

Gross margin was 28.8% versus 26.3% a year earlier, operating margin was 18.8% versus 16.7%, and net margin was 12.1% versus 11.9%. Each margin ranks third among seven comparable September quarters, a strong but not unprecedented result on a like-for-like basis. Net profit rose 15.8% to LKR 12.4 billion, while LKR 7.0 billion was absorbed below operating profit by finance costs, tax, associates and other non-operating items.

The latest audited year, ended March 2026, was weaker: net profit fell 47.5% to LKR 17.9 billion and return on equity was 6.3%. The September filing is later than that annual result and shows a recovery, but it does not yet establish a full-year outcome. Equity attributable to owners was LKR 83.1 billion at September, while ordinary shares in issue today total 102 million.

Risks

The largest ownership risk is that 74.1% of audited FY2026 group profit belonged to minority shareholders rather than BUKI's ordinary shareholders. Group net profit can therefore look much larger than the profit pot underlying the shares and EPS being valued.

Debt was 105.8% of owners' equity at March 2026, meaning borrowings slightly exceeded the equity attributable to shareholders. Operating profit covered the interest bill 4.06 times, which provides cover but leaves financing costs meaningful if operating earnings weaken. The current ratio was 1.94 times, meaning current assets, including inventory and customer balances, exceeded bills due within a year; annual operating cash flow was 1.47 times operating profit, so that year's operating earnings were cash-backed.

The consumer-retail backdrop accounts for 65% of reported segment revenue and remains price-sensitive, while the sector backdrop also identifies an excise disparity between imported and domestic alcohol. Plantations account for the remaining 35% of segment revenue and face higher transport costs alongside constrained investment conditions.

Outlook

As at 14 November 2026, the next defined company event is the interim filing for the quarter ending 31 December 2026, expected between 6 and 14 February 2027. It will show whether the September operating recovery continued through another quarter and will supersede the financial evidence used here.

The data cannot separate the contribution of each operating segment to the September improvement. It also cannot determine how the price-sensitive consumer environment or plantation cost pressures have affected BUKI specifically; those are sector conditions, not company disclosures.

About this report. Generated on Nov 14, 2026 from market data up to Nov 13, 2026, 4 material news articles over 90 days and financials to Sep 30, 2026, and scored 61 of 100 on value (moderately undervalued) when it was written. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.

Previous reports